1. Sutherland ,EW, Rall ,TW: Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. JBC 232: 1077–1091, 1958
2. Waldman ,SA, Murad ,F: Cyclic GMP synthesis and function. Pharmacological Reviews 39: 163–196, 1987
3. Reeves ,ML, England ,PJ: Cardiac phosphodiesterases and the functional effects of selective inhibition. In: JA Beavo, MD Housley (eds) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action. John Wiley & Sons, Ltd., Chichester, 1990, pp 299–316
4. Sonnenburg ,WK, Beavo ,JA: Cyclic GMP and regulation of cyclic nucleotide hydrolysis. In: F Murad (ed.) Cyclic GMP: synthesis, metabolism, and function. Academic Press, San Diego, 1992, in press
5. Harrison ,SA, Reifsnyder ,DH, Gallis ,B, Cadd ,GC, Beavo ,JA: Isolation and characterization of bovine cardiac muscle cGMP-in-hibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Phcol 29: 506–514, 1986